ATE209917T1 - Verfahren zur herstellung von ophtalmischen suspensionen enthaltend brinzolamid - Google Patents
Verfahren zur herstellung von ophtalmischen suspensionen enthaltend brinzolamidInfo
- Publication number
- ATE209917T1 ATE209917T1 AT97939835T AT97939835T ATE209917T1 AT E209917 T1 ATE209917 T1 AT E209917T1 AT 97939835 T AT97939835 T AT 97939835T AT 97939835 T AT97939835 T AT 97939835T AT E209917 T1 ATE209917 T1 AT E209917T1
- Authority
- AT
- Austria
- Prior art keywords
- ophtalmic
- producing
- suspensions containing
- brinzolamide
- containing brinzolamide
- Prior art date
Links
- HCRKCZRJWPKOAR-JTQLQIEISA-N brinzolamide Chemical compound CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 HCRKCZRJWPKOAR-JTQLQIEISA-N 0.000 title abstract 3
- 229960000722 brinzolamide Drugs 0.000 title abstract 3
- 239000000725 suspension Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000002876 beta blocker Substances 0.000 abstract 1
- 229940097320 beta blocking agent Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3282096P | 1996-12-11 | 1996-12-11 | |
| US08/886,933 US6071904A (en) | 1996-12-11 | 1997-07-02 | Process for manufacturing ophthalmic suspensions |
| PCT/US1997/015727 WO1998025620A1 (en) | 1996-12-11 | 1997-09-05 | Process for manufacturing ophthalmic suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209917T1 true ATE209917T1 (de) | 2001-12-15 |
Family
ID=26708929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97939835T ATE209917T1 (de) | 1996-12-11 | 1997-09-05 | Verfahren zur herstellung von ophtalmischen suspensionen enthaltend brinzolamid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6071904A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0941094B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3611863B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE209917T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2274680C (cg-RX-API-DMAC7.html) |
| DE (2) | DE122009000016I1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0941094T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2169416T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR09C0022I2 (cg-RX-API-DMAC7.html) |
| LU (1) | LU91554I2 (cg-RX-API-DMAC7.html) |
| NL (1) | NL300388I2 (cg-RX-API-DMAC7.html) |
| PT (1) | PT941094E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998025620A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001365A1 (en) * | 1998-06-30 | 2000-01-13 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) | Prolonged release ophthalmic compositions containing a fluoroquinolone |
| US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
| MXPA03010634A (es) | 2001-05-21 | 2004-03-09 | Alcon Inc | Uso de inhibidores de proteasoma para tratar trastornos del ojo seco. |
| CA2447918A1 (en) * | 2001-05-21 | 2002-11-28 | Alcon, Inc. | Method of treating dry eye disorders |
| CN1509462A (zh) | 2001-05-21 | 2004-06-30 | NF-κB抑制剂在治疗干眼疾病中的用途 | |
| US7112588B2 (en) * | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
| TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
| WO2003074027A2 (en) * | 2002-03-01 | 2003-09-12 | Novagali Pharma Sa | Self emulsifying drug delivery systems for poorly soluble drugs |
| KR101059711B1 (ko) | 2003-01-21 | 2011-08-29 | 센주 세이야꾸 가부시키가이샤 | 2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성액제 |
| US7892483B2 (en) * | 2004-03-12 | 2011-02-22 | Cipla Limited | Sterilization process |
| SI1891939T1 (sl) * | 2006-07-28 | 2013-11-29 | Novagali Pharma S.A. | Sestave vsebujoče kvaternarne amonijeve spojine |
| WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
| TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
| TWI489997B (zh) * | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸－多元醇錯合物之水性藥學組成物 |
| JP5558582B2 (ja) * | 2009-12-03 | 2014-07-23 | ルピン・リミテッド | 眼科用医薬組成物の調製方法 |
| EP2394637A1 (en) * | 2010-05-21 | 2011-12-14 | Zaklady Farmaceutyczne Polpharma SA | Process for obtaining sterile brinzolamide suspensions |
| US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| EP2598118B1 (en) | 2010-07-29 | 2018-09-05 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
| WO2012053011A2 (en) | 2010-10-18 | 2012-04-26 | Usv Limited | Ophthalmic compositions comprising brinzolamide |
| WO2013025696A1 (en) | 2011-08-15 | 2013-02-21 | Teva Pharmaceutical Industries Ltd. | Ophthalmic formulations and processes for their preparation |
| EP2638909A1 (en) | 2012-03-15 | 2013-09-18 | Azad Pharmaceutical Ingredients AG | Process for preparing sterile Brinzolamide |
| GR1007906B (el) * | 2012-03-22 | 2013-05-30 | Φαρματεν Αβεε, | Οφθαλμικο φαρμακευτικο σκευασμα περιεχον ενα αναστολεα καρβονικης ανυδρασης και μεθοδος για την παρασκευη αυτου |
| WO2013168186A1 (en) | 2012-05-09 | 2013-11-14 | Icrom Spa | Production of sterile active pharmaceutical ingredients |
| US20150119386A1 (en) * | 2012-05-21 | 2015-04-30 | Aurobindo Pharma Limited | Process for preparing opthalmic suspension of brinzolamide |
| EP2906198B1 (en) | 2012-10-11 | 2019-04-03 | Indoco Remedies Limited | A process for manufacturing sterile brinzolamide ophthalmic suspension |
| CN104721136A (zh) * | 2013-02-21 | 2015-06-24 | 四川大学 | 一种布佐林胺眼用纳米混悬剂及其制备方法 |
| WO2015056149A1 (en) * | 2013-10-17 | 2015-04-23 | Sentiss Pharma Private Limited | Preservative-free ophthalmic pharmaceutical formulation |
| US10463674B2 (en) | 2013-11-08 | 2019-11-05 | Sentiss Pharma Private Limited | Process for manufacturing sterile ophthalmic pharmaceutical suspensions |
| US9820991B2 (en) * | 2013-11-08 | 2017-11-21 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
| ES2838756T3 (es) | 2014-01-24 | 2021-07-02 | Sentiss Pharma Private Ltd | Composición farmacéutica que comprende brinzolamida |
| PL407710A1 (pl) | 2014-03-28 | 2015-10-12 | Instytut Farmaceutyczny | Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem |
| JP6279395B2 (ja) * | 2014-05-01 | 2018-02-14 | 東亜薬品株式会社 | ブリンゾラミド懸濁性点眼液組成物の製造方法 |
| JP6704400B2 (ja) * | 2014-10-20 | 2020-06-03 | センティス・ファーマ・プライヴェート・リミテッド | 眼科用液剤 |
| TWI664965B (zh) * | 2015-06-22 | 2019-07-11 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法 |
| CN107582519A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 一种布林佐胺滴眼液制剂及其制备方法 |
| GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| US11298360B2 (en) | 2018-04-25 | 2022-04-12 | Shilpa Medicare Limited | Ophthalmic compositions of brinzolamide |
| GR1009616B (el) * | 2018-07-20 | 2019-10-11 | Φαρματεν Α.Β.Ε.Ε. | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει βρινζολαμιδη και τιμολολη και μεθοδος παρασκευης αυτου |
| MX2021014477A (es) | 2019-05-29 | 2022-01-06 | Lupin Ltd | Nanoemulsion gelificante in situ de brinzolamida. |
| US11850249B2 (en) | 2020-10-05 | 2023-12-26 | Somerset Therapeutics, Llc | Methods of efficiently reducing intraocular pressure |
| WO2024236599A1 (en) | 2023-05-16 | 2024-11-21 | Micro Labs Limited | Ophthalmic solution of brinzolamide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
| WO1992018124A1 (en) * | 1991-04-17 | 1992-10-29 | Merck & Co., Inc. | OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST |
| CA2129037C (en) * | 1992-02-21 | 1998-03-24 | Thomas Robert Dean | Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5429824A (en) * | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
-
1997
- 1997-07-02 US US08/886,933 patent/US6071904A/en not_active Expired - Lifetime
- 1997-09-05 WO PCT/US1997/015727 patent/WO1998025620A1/en not_active Ceased
- 1997-09-05 AT AT97939835T patent/ATE209917T1/de active
- 1997-09-05 DE DE122009000016C patent/DE122009000016I1/de active Pending
- 1997-09-05 ES ES97939835T patent/ES2169416T3/es not_active Expired - Lifetime
- 1997-09-05 DK DK97939835T patent/DK0941094T3/da active
- 1997-09-05 PT PT97939835T patent/PT941094E/pt unknown
- 1997-09-05 EP EP97939835A patent/EP0941094B1/en not_active Expired - Lifetime
- 1997-09-05 JP JP52598698A patent/JP3611863B2/ja not_active Expired - Lifetime
- 1997-09-05 DE DE69708912T patent/DE69708912T2/de not_active Expired - Lifetime
- 1997-09-05 CA CA002274680A patent/CA2274680C/en not_active Expired - Lifetime
-
2009
- 2009-04-22 LU LU91554C patent/LU91554I2/fr unknown
- 2009-05-11 NL NL300388C patent/NL300388I2/nl unknown
- 2009-05-25 FR FR09C0022C patent/FR09C0022I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU718079B2 (en) | 2000-04-06 |
| EP0941094B1 (en) | 2001-12-05 |
| ES2169416T3 (es) | 2002-07-01 |
| FR09C0022I1 (cg-RX-API-DMAC7.html) | 2009-09-25 |
| NL300388I2 (nl) | 2010-02-01 |
| WO1998025620A1 (en) | 1998-06-18 |
| JP2000501749A (ja) | 2000-02-15 |
| FR09C0022I2 (cg-RX-API-DMAC7.html) | 2010-06-11 |
| HK1019704A1 (en) | 2000-02-25 |
| JP3611863B2 (ja) | 2005-01-19 |
| NL300388I1 (nl) | 2009-07-01 |
| DE122009000016I1 (de) | 2009-06-25 |
| EP0941094A1 (en) | 1999-09-15 |
| CA2274680A1 (en) | 1998-06-18 |
| DE69708912D1 (de) | 2002-01-17 |
| LU91554I2 (fr) | 2009-06-22 |
| DK0941094T3 (da) | 2002-01-07 |
| DE69708912T2 (de) | 2002-04-11 |
| CA2274680C (en) | 2003-11-18 |
| AU4183897A (en) | 1998-07-03 |
| US6071904A (en) | 2000-06-06 |
| PT941094E (pt) | 2002-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69708912D1 (de) | Verfahren zur herstellung von ophtalmischen suspensionen enthaltend brinzolamid | |
| DE69426870D1 (de) | Verfahren zur herstellung von aminochinolinen | |
| DE59009607D1 (de) | Verfahren zur Herstellung von Hörgeräten. | |
| DE69605167D1 (de) | Verfahren zur Herstellung von Polycarbonat | |
| DE69412597D1 (de) | Methode zur herstellung von gelatine | |
| DE69527818D1 (de) | Verfahren zur Herstellung von Polycarbonaten | |
| DE69603314D1 (de) | Verfahren zur Herstellung von Sulfiden | |
| DE59504792D1 (de) | Verfahren zur Herstellung von Serienventilen | |
| DE69628421D1 (de) | Verfahren zur herstellung von tetraazacycloalkanen. | |
| DE59611017D1 (de) | Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen | |
| DE69428845D1 (de) | Verfahren zur Herstellung von Sende-Empfängern | |
| DE59611044D1 (de) | Verfahren zur Herstellung von verbrückten Metallocenkomplexen | |
| DE69414253D1 (de) | Verfahren zur herstellung von oximin | |
| DE68927606D1 (de) | Verfahren zur Produktion von Halbtondaten | |
| DE69403571D1 (de) | Verfahren zur Herstellung von Acrylamid | |
| DE69425496D1 (de) | Verfahren zur herstellung von 1,4-dienen | |
| DE69608384D1 (de) | Verfahren zur Herstellung von elastomeren Ethylen-Propylen-Copolymeren | |
| DE69618481D1 (de) | Verfahren zur herstellung von halogenkohlenwasserstoffen | |
| DE69408873D1 (de) | Verfahren zur herstellung von carbamaten | |
| DE59401406D1 (de) | Verfahren zur herstellung von naphtalocyaninen | |
| DE59106553D1 (de) | Verfahren zur herstellung von chlorfluornitrobenzolen und difluornitrobenzolen. | |
| DE69603261D1 (de) | Verfahren zur herstellung von 1,2-benzisothiazolonen | |
| DE58903851D1 (de) | Verfahren zur herstellung von n-alkylierten anilinen. | |
| DE59404478D1 (de) | Verfahren zur herstellung von polyvinylpyridin-n-oxiden | |
| DE69611331D1 (de) | Verfahren zur Herstellung von S-Phenyl-L-Cystein |